Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One day versus three days of prednisolone for preschool wheeze
ACTRN12625001112459Phase 3Not yet recruiting
- Sponsor
- Te Whatu Ora
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of prednisolone and Placebo-COD Research Private Ltd in asthma and episodic viral wheeze (EVW) (2 arms), sponsored by Te Whatu Ora. Primary endpoint: Composite primary outcome. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
prednisolonePlacebo-COD Research Private Ltd
03
Conditions
asthmaepisodic viral wheeze (EVW)
Beyond the preview
Go deeper on ACTRN12625001112459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001112459.